pta20260902015 Unternehmensmitteilung für den Kapitalmarkt Epigenomics AG: Kapitalerhöhung in Höhe von EUR 219.244,00 vollständig gezeichnet Heidelberg (pta015/02.09.2026/12:35 UTC+2) Heidelberg, 2. September 2026 – Die Epigenomics AG gibt bekannt, dass im Rahmen der Bezugsrechtskapitalerhöhung mit folgender Privatplatzierung, welche heute beendet wurde, insgesamt 219.244 neue Aktien zum Bezugspreis von 1,00 EUR je Aktie gezeichnet wurden und somit […]
Category: Press Releases
02. September 2026
Epigenomics AG: Capital increase in the amount of EUR 219,244.00 fully subscribed
30. April 2024
Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024
EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024 30.04.2024 / 15:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024 Berlin (Germany), April 30, 2024 – Jens Ravens, Executive […]
14. March 2024
Epigenomics AG publishes financial results for fiscal year 2023
EQS-News: Epigenomics AG / Key word(s): Annual Results/Annual ReportEpigenomics AG publishes financial results for fiscal year 2023 14.03.2024 / 08:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG publishes financial results for fiscal year 2023 Berlin (Germany), March 14, 2024 – Epigenomics AG (FSE: ECX, the “Company”) today reported financial […]
15. February 2024
Epigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet
EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet 15.02.2024 / 10:00 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet Berlin, February 15, 2024 – Epigenomics AG (Frankfurt General […]
31. January 2024
Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board
EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board 31.01.2024 / 15:30 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Supervisory Board of Epigenomics AG appoints Hansjörg Plaggemars as member of the Executive Board Berlin, January 31, […]
26. January 2024
Epigenomics AG: Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD)
EQS-News: Epigenomics AG / Key word(s): PersonnelEpigenomics AG: Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD) 26.01.2024 / 13:16 CET/CESTThe issuer is solely responsible for the content of this announcement. Epigenomics AG: Resignation of Supervisory Board Member Dr Heikki Lanckriet (PhD) Berlin, Germany, January 26, 2024 – Dr Heikki Lanckriet (PhD) has informed the competent bodies of Epigenomics AG […]
